Form 4: Director Boosts Stake in Aspira Women's Health
Insider Transaction Report
Aspira Women's Health Director and 10% Owner Jack W. Schuler acquired over 1.1 million shares and 833,333 warrants through his living trust.
Summary
- Jack W. Schuler, a Director and 10% Owner of Aspira Women's Health Inc. (AWHL), reported an acquisition of securities.
- On September 17, 2025, Mr. Schuler's Living Trust acquired 1,111,111 shares of Common Stock at a price of $0.45 per share.
- Following this transaction, the Jack W. Schuler Living Trust beneficially owns 3,823,829 shares of Common Stock indirectly, and Mr. Schuler directly owns 6,536 shares.
- The Living Trust also acquired 833,333 warrants to buy Common Stock, with an exercise price of $0.75 per share, exercisable from September 17, 2025, and expiring on September 17, 2030.
- The reported price for the acquisition of these derivative warrants was $0.
- The transaction was made pursuant to a Rule 10b5-1(c) contract, instruction, or written plan for the purchase or sale of equity securities.
Sentiment
Score: 9
Explanation: The significant acquisition of common stock and warrants by a Director and 10% owner, especially through a living trust and under a 10b5-1 plan, indicates strong insider confidence in the company's valuation and future prospects.
Positives
- Significant insider buying by a Director and 10% owner, Jack W. Schuler, signals strong confidence in the company's future prospects.
- The acquisition of 1,111,111 common shares and 833,333 warrants increases insider ownership, aligning management and shareholder interests.
- The transaction was executed under a Rule 10b5-1 plan, indicating a pre-planned investment strategy.
Negatives
- No explicit negatives are detailed in this insider transaction filing.
Risks
- No specific risks are detailed in this insider transaction filing.
Future Outlook
The filing indicates a pre-arranged trading plan under Rule 10b5-1(c), suggesting a long-term investment strategy by the insider. No specific forward-looking statements regarding company performance or guidance are provided.
Industry Context
This Form 4 filing reports an insider transaction and does not provide information related to broader industry trends or competitors.
Related Party Transactions
- Jack W. Schuler, a Director and 10% owner of Aspira Women's Health Inc., acquired common stock and warrants, which constitutes a related party transaction.
Stakeholder Impact
- Shareholders may view this significant insider purchase as a positive signal, potentially increasing investor confidence in the company's future performance and valuation.
Key Dates
| Date | Description |
|---|---|
| 08/25/2022 | Date Exercisable for 8,888 indirect warrants with a $4.13 strike price. |
| 07/09/2024 | Date Exercisable for 6,536 direct warrants with a $2.25 strike price. |
| 07/26/2024 | Date Exercisable for 28,500 indirect warrants with a $4.13 strike price. |
| 03/12/2025 | Date Exercisable for 1,801,265 indirect warrants with a $0.25 strike price. |
| 09/17/2025 | Transaction Date for the acquisition of 1,111,111 common shares and 833,333 warrants. Also, the Date Exercisable for the newly acquired 833,333 warrants. |
| 09/18/2025 | Signature Date of the Reporting Person. |
| 07/09/2027 | Expiration Date for 6,536 direct warrants with a $2.25 strike price. |
| 01/26/2029 | Expiration Date for 8,888 indirect warrants with a $4.13 strike price. |
| 07/26/2029 | Expiration Date for 28,500 indirect warrants with a $4.13 strike price. |
| 03/12/2030 | Expiration Date for 1,801,265 indirect warrants with a $0.25 strike price. |
| 09/17/2030 | Expiration Date for the newly acquired 833,333 warrants with a $0.75 strike price. |
Recommendation
strong buyA substantial insider purchase by a Director and 10% owner, particularly when executed through a pre-planned Rule 10b5-1 program, often signals a strong belief in the company's undervaluation or significant future growth potential. This action by a well-informed insider provides a compelling positive signal for investors, suggesting a 'strong buy' recommendation.
Keywords
Aspira Women's Health, AWHL, Insider Trading, Form 4, Director Purchase, Stock Acquisition, Warrants, Rule 10b5-1, Beneficial Ownership
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.